Novel crystalline forms of a vegf-r inhibitor

The present invention relates to novel crystalline polymorphic and amorphous form of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole and to methods for their preparation. The invention is also directed to pharmaceutical compositions containing at least one polymorphic for...

Full description

Saved in:
Bibliographic Details
Main Authors MCLAUGHLIN, ROBERT WILLIAM, CAMPETA, ANTHONY MICHAEL, CHEKAL, BRIAN PATRICK, SINGER, ROBERT ALAN
Format Patent
LanguageChinese
English
Published 21.04.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to novel crystalline polymorphic and amorphous form of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole and to methods for their preparation. The invention is also directed to pharmaceutical compositions containing at least one polymorphic form and to the therapeutic or prophylactic use of such polymorphic forms and compositions.
AbstractList The present invention relates to novel crystalline polymorphic and amorphous form of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole and to methods for their preparation. The invention is also directed to pharmaceutical compositions containing at least one polymorphic form and to the therapeutic or prophylactic use of such polymorphic forms and compositions.
Author CAMPETA, ANTHONY MICHAEL
MCLAUGHLIN, ROBERT WILLIAM
SINGER, ROBERT ALAN
CHEKAL, BRIAN PATRICK
Author_xml – fullname: MCLAUGHLIN, ROBERT WILLIAM
– fullname: CAMPETA, ANTHONY MICHAEL
– fullname: CHEKAL, BRIAN PATRICK
– fullname: SINGER, ROBERT ALAN
BookMark eNrjYmDJy89L5WTQ9csvS81RSC6qLC5JzMnJzEtVSMsvyi1WyE9TSFQoS01P0y1SyMzLyEzKLMkv4mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8SHhniYWhmYGRk5OxkQoAQBbeSvA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID TWI481602BB
GroupedDBID EVB
ID FETCH-epo_espacenet_TWI481602BB3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:58:16 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_TWI481602BB3
Notes Application Number: TW200897112383
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150421&DB=EPODOC&CC=TW&NR=I481602B
ParticipantIDs epo_espacenet_TWI481602BB
PublicationCentury 2000
PublicationDate 20150421
PublicationDateYYYYMMDD 2015-04-21
PublicationDate_xml – month: 04
  year: 2015
  text: 20150421
  day: 21
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies PFIZER PRODUCTS INC
RelatedCompanies_xml – name: PFIZER PRODUCTS INC
Score 3.0959454
Snippet The present invention relates to novel crystalline polymorphic and amorphous form of...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title Novel crystalline forms of a vegf-r inhibitor
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150421&DB=EPODOC&locale=&CC=TW&NR=I481602B
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp-L8Ig_St2DT9WN9KEI_xhTWDalub2NJ2nUg2-jqRP96L2VTX_QtJHBJLrnc73K5C8Ct3eaWw12LMtESFDcFpxOHSao7vGXh-huCqeDkXmx3n83HkTWqQb6NhanyhL5XyRFRogTKe1md18ufS6ywelu5uuMzrFrcdxIv1DbWMaIb02Ba6HvRoB_2Ay0IvGSoxU_eg9lmtm74O7CrQLTKsh-9-ComZflboXSOYG-AtOblMdQ-8wYcBNt_1xqw39u4u7G4kbzVCdB4sU5fiSg-EM6pPNopUXBzRRYZmZB1Os1oQWbzfMZRRItTIJ0oCboU-x1_T3GcDLcD9FtnUEfLPz0HIqXN-YTLTJiu6diua0huCV26ss301HSa0PyTzMU_bZdwqHilnCIGu4J6Wbyl16hbS35TseULaQN-0A
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUQN-9sHsrXEd-2APi8k2CCgMYqbwRmg7hMQA2SZG_3pvy1Bf9K1pk-v12mvv1-tdAW7MJjcsbhuUiYaguCg4nVpMUtXiDQPnXxMsC07uB2bnSb8fG-MSzLexMHme0Pc8OSJqlEB9T_P9ev1zieXnbyuTW77AqtVdO3R8pUDHaN3oGlN812kNB_7AUzzPCUdK8Oh09SYzVc3dgV0LAWEOlJ7dLCZl_ftAaR_C3hBpLdMjKH3Oq1Dxtv-uVWG_X7i7sVhoXnIMNFhtolci4g8057I82hHJzM2ErGZkSjbRy4zGZLGcLziqaHwCpN0KvQ7FfiffQ5yEoy2DbuMUyoj8oxoQKU3Op1zOhG7ryLatSW4IVdqyydRIt-pQ_5PM2T9t11DphP3epNcNHs7hIJNb5iDR2AWU0_gtusRzNuVXuYi-AHwFgbo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Novel+crystalline+forms+of+a+vegf-r+inhibitor&rft.inventor=MCLAUGHLIN%2C+ROBERT+WILLIAM&rft.inventor=CAMPETA%2C+ANTHONY+MICHAEL&rft.inventor=CHEKAL%2C+BRIAN+PATRICK&rft.inventor=SINGER%2C+ROBERT+ALAN&rft.date=2015-04-21&rft.externalDBID=B&rft.externalDocID=TWI481602BB